Literature DB >> 9700379

Tubular apocrine carcinoma arising in a nevus sebaceus of Jadassohn.

W K Jacyk1, L Requena, E Sánchez Yus, M J Judd.   

Abstract

We present an example of tubular carcinoma that developed within a nevus sebaceus of Jadassohn on the scalp of a 53-year-old woman. The neoplasm showed features of sebaceous and apocrine differentiation. We review the literature about the malignant neoplasms arising in the nevus sebaceus of Jadassohn.

Entities:  

Mesh：

Year:  1998        PMID： 9700379     DOI： 10.1097/00000372-199808000-00012

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN： 0193-1091            Impact factor:   1.533


  5 in total

1.  Dermoscopic Analysis of Nevus Sebaceus of Jadassohn: A Study of 13 Cases.

Authors:  Awatef Kelati; Hanane Baybay; Salim Gallouj; Fatima Zahra Mernissi
Journal:  Skin Appendage Disord       Date:  2017-03-16

2.  Brain metastases from apocrine carcinoma of the scalp: case report.

Authors:  Shinji Shimato; Toshihiko Wakabayashi; Masaaki Mizuno; Norimoto Nakahara; Hisashi Hatano; Atsushi Natsume; Dai Ishii; Yasuhisa Hasegawa; Ikuo Hyodo; Tetsuro Nagasaka; Jun Yoshida
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

3.  Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature.

Authors:  Hadi Al-Hakami; Baraa I Awad; Mohammed Al-Garni; Haneen A Al-Maghrabi; Noura Al-Shareef
Journal:  J Family Med Prim Care       Date:  2019-11-15

Review 4.  Primary cutaneous apocrine carcinoma of the scalp: Two case reports and literature review.

Authors:  Jun Ho Choi; Hyun Myung Oh; Kwang Seog Kim; Yoo Duk Choi; Sung Pil Joo; Won Joo Hwang; Jae Ha Hwang; Sam Yong Lee
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

Review 5.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.